These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24786324)

  • 1. Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis.
    Das S; Freier A; Boussoffara T; Das S; Oswald D; Losch FO; Selka M; Sacerdoti-Sierra N; Schönian G; Wiesmüller KH; Seifert K; Schroff M; Juhls C; Jaffe CL; Roy S; Das P; Louzir H; Croft SL; Modabber F; Walden P
    Sci Transl Med; 2014 Apr; 6(234):234ra56. PubMed ID: 24786324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
    Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using humans to make a human leishmaniasis vaccine.
    Kamhawi S; Oliveira F; Valenzuela JG
    Sci Transl Med; 2014 Apr; 6(234):234fs18. PubMed ID: 24786322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis.
    Lakshmi BS; Wang R; Madhubala R
    Vaccine; 2014 Jun; 32(30):3816-22. PubMed ID: 24814525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY; Singleton A; Cillari E; Howard JG
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine.
    Riede O; Seifert K; Oswald D; Endmann A; Hock C; Winkler A; Salguero FJ; Schroff M; Croft SL; Juhls C
    Gene Ther; 2015 Aug; 22(8):628-35. PubMed ID: 25871827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunology of Leishmania infection and the implications for vaccine development.
    Vanloubbeeck Y; Jones DE
    Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
    Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
    Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
    Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inducement of cytotoxic T cell responses in mice by constructing a multi-CTL epitope-based DNA vaccine].
    Shi L; Yuan YK; Sheng L; Fan GX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):430-2. PubMed ID: 16806000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
    Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
    West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
    Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
    Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.